Upcoming events on PFIZER, INC. |
|
07/28/22 | | Ex-dividend day for |
07/28/22 | | Interim 2022 Earnings Release |
07/28/22 | 10:00am | | Interim 2022 Earnings Call |
11/01/22 | | Q3 2022 Earnings Release (Projected) |
01/31/23 | | FY 2022 Earnings Release (Projected) |
05/02/23 | | Q1 2023 Earnings Release (Projected) |
08/01/23 | | Interim 2023 Earnings Release (Projected) |
|
Past events on PFIZER, INC. |
|
06/16/22 | 05:40am | | Storebrand Invest in the Future Conference |
06/15/22 | 11:40am | | Goldman Sachs Global Healthcare Conference |
06/06/22 | 03:45pm | | Business Update Call |
06/01/22 | 09:00am | | Bernstein Strategic Decisions Conference |
05/24/22 | 04:00pm | | Digestive Disease Week |
05/12/22 | | Ex-dividend day for |
05/10/22 | 10:00am | | Acquisition of Biohaven Pharmaceutical Holding Co Ltd by Pfizer Inc Call |
05/03/22 | 10:00am | | Q1 2022 Earnings Call |
05/03/22 | 06:45am | | Q1 2022 Earnings Release |
04/28/22 | 09:00am | | Annual General Meeting |
|
Past dividends on PFIZER, INC. |
|
05/12/22 | | Quarterly 0.4 USD |
01/27/22 | | Quarterly 0.4 USD |
11/04/21 | | Quarterly 0.39 USD |
07/29/21 | | Quarterly 0.39 USD |
05/06/21 | | Quarterly 0.39 USD |
01/28/21 | | Quarterly 0.39 USD |
11/17/20 | | 0 |
11/05/20 | | Quarterly 0.38 USD |
07/30/20 | | Quarterly 0.38 USD |
05/07/20 | | Quarterly 0.38 USD |
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 52 546 52 524 0,04% | 53 647 53 582 0,12% | 51 750 51 807 -0,11% | 41 908 48 014 -13% | 81 288 81 781 -0,60% | 103 863 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 21 172 21 875 -3,2% | 21 814 21 615 0,92% | 21 097 22 824 -7,6% | 17 801 21 398 -17% | 25 426 29 444 -14% | 47 424 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 19 468 19 859 -2,0% | 20 042 19 998 0,22% | 19 420 19 883 -2,3% | 13 024 17 362 -25% | 20 235 26 662 -24% | 42 648 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 12 305 14 925 -18% | 11 885 16 386 -27% | 17 682 22 426 -21% | 7 497 13 166 -43% | 24 311 19 569 24% | 43 648 |
Net income M $ |
Released Forecast Spread | 21 308 11 574 84% | 11 153 14 121 -21% | 16 273 19 053 -15% | 9 616 16 066 -40% | 21 979 22 567 -2,6% | 35 924 |
EPS $ |
Released Forecast Spread | 3,52 1,88 87% | 1,87 2,38 -21% | 2,87 3,40 -16% | 1,71 2,82 -39% | 3,85 3,89 -0,90% | 6,01 | Announcement Date | 01/30/2018 | 01/29/2019 | 01/28/2020 | 02/02/2021 | 02/08/2022 | - |
|
|
Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales M $ |
Released Forecast Spread | 12 028 11 743 2,4% | 11 801 11 553 2,1% | 12 131 12 298 -1,4% | 11 684 11 304 3,4% | 14 582 13 621 7,1% | 18 977 18 727 1,3% | 24 094 22 810 5,6% | 23 838 24 203 -1,5% | 25 661 24 734 3,7% | 26 115 | 25 736 | 24 638 | 21 500 | 20 100 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 5 539 5 220 6,1% | 5 279 5 180 1,9% | 5 595 5 090 9,9% | 3 114 3 594 -13% | 6 850 5 470 25% | 8 243 8 414 -2,0% | 9 876 8 725 13% | 4 403 6 196 -29% | 11 135 13 710 -19% | 12 589 | 13 485 | 10 180 |
|
|
Operating profit (EBIT) M $ |
Released Forecast Spread | 5 135 4 535 13% | 4 791 4 175 15% | 4 333 4 505 -3,8% | 2 068 3 337 -38% | 5 624 4 659 21% | 6 746 5 527 22% | 8 516 6 536 30% | 3 126 5 610 -44% | 9 948 9 738 2,2% | 10 423 | 11 864 | 10 320 |
|
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread |
|
|
|
|
|
|
|
| 9 050
|
|
|
|
|
|
Net income M $ |
Released Forecast Spread | 3 401
|
| 2 194 3 215 -32% | 594 3 343 -82% | 4 877 3 829 27% | 5 563 4 548 22% | 8 146 3 829 113% | 3 393 5 046 -33% | 7 864 8 418 -6,6% | 9 530 | 9 859 | 9 385 |
|
|
EPS $ |
Released Forecast Spread | 0,61 0,47 29% |
| 0,39 0,57 -32% | 0,10 0,40 -75% | 0,86 0,69 25% | 0,98 0,76 30% | 1,42 1,03 38% | 0,59 0,74 -20% | 1,37 1,60 -14% | 1,56 | 1,61 | 1,48 |
|
| Announcement Date | 04/28/2020 | 07/28/2020 | 10/27/2020 | 02/02/2021 | 05/04/2021 | 07/28/2021 | 11/02/2021 | 02/08/2022 | 05/03/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for PFIZER, INC. |
|
|
|
Past sector events for PFIZER, INC. |
|
|
|
|
|
|
Pharmaceutical companies still have the upper hand |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|